Edition:
India

China Resources Double-Crane Pharmaceutical Co Ltd (600062.SS)

600062.SS on Shanghai Stock Exchange

24.03CNY
18 Jan 2018
Change (% chg)

¥-0.24 (-0.99%)
Prev Close
¥24.27
Open
¥24.95
Day's High
¥24.95
Day's Low
¥23.81
Volume
5,820,503
Avg. Vol
6,918,835
52-wk High
¥25.58
52-wk Low
¥18.28

Latest Key Developments (Source: Significant Developments)

China Resources Double-crane Pharmaceutical to set up medical industrial investment LP with partners
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - China Resources Double-crane Pharmaceutical Co Ltd <600062.SS> ::Says it plans to invest 50 million yuan to set up an medical industrial investment limited partnership worth totaling 2.5 billion yuan, with partners.  Full Article

China Resources Double-Crane Pharmaceutical's 9-month net profit up 20.5 pct y/y
Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS>:Says its 9-month net profit up 20.5 percent y/y at 724.9 million yuan ($109.34 million).  Full Article

China Resources Double-crane Pharmaceutical to pay FY 2016 annual div on July 17
Monday, 10 Jul 2017 

July 10(Reuters) - China Resources Double-crane Pharmaceutical Co Ltd <600062.SS> ::* Says it will pay FY 2016 dividend to shareholders of record on July 14.* The company's shares will be traded ex-right and ex-dividend on July 17 and the dividend will be paid on July 17.  Full Article

China Resources Double-Crane Pharma's H1 net profit up 5.6 pct
Monday, 15 Aug 2016 

China Resources Double-Crane Pharmaceutical Co Ltd <600062.SS> :Says its H1 net profit up 5.6 pct y/y at 433.5 million yuan ($65.22 million).  Full Article

China Resources Double-Crane Pharmaceutical to pay 2015 div on July 20
Wednesday, 13 Jul 2016 

China Resources Double-Crane Pharmaceutical <600062.SS> Co., Ltd.: Says it will pay cash dividend of 1.85 yuan per 10 shares (before tax) to shareholders for 2015 as a record of July 19 .Says the company's shares will be traded ex-right and ex-dividend on July 20 and the dividend will be paid on July 20.  Full Article

China Resources Double-Crane Pharmaceutical passes CEP approval
Wednesday, 23 Mar 2016 

China Resources Double-Crane Pharmaceutical Co Ltd:Receives approval for its olmesartan medoxomil from European Directorate for Quality of Medicines & HealthCare.Company will be able to sell its olmesartan medoxomil in Europe after receiving the CEP approval.  Full Article

China Resources Double-Crane Pharmaceutical says 2015 dividend payment as 0.185 yuan per share
Friday, 11 Mar 2016 

China Resources Double-Crane Pharmaceutical Co Ltd:To pay cash dividend of 1.85 yuan per 10 shares (before tax) to the company's shareholders for 2015.  Full Article

China Resources Double-Crane Pharmaceutical subsidiary drug clinical trials approval document
Wednesday, 2 Mar 2016 

China Resources Double-Crane Pharmaceutical Co Ltd:Wholly owned subsidiary drug clinical trials approval document, for ezetimibe tablets (10mg).  Full Article

China Resources Double-Crane Pharmaceutical gets nod for clinic trial
Wednesday, 17 Feb 2016 

China Resources Double-Crane Pharmaceutical Co Ltd:Says gets China Food and Drug Administration's approval for its ultrasonic contrast agent injection's clinic trial.  Full Article

China Resources Double-Crane Pharmaceutical subsidiary receives drug clinical trial permission
Friday, 5 Feb 2016 

China Resources Double-Crane Pharmaceutical Co Ltd:Says its subsidiary receives drug clinical trial permission for strontium ranelate for suspension.  Full Article